Team
health

Newborn Hyperbilirubinemia Assessment Calculator

Neonatal jaundice affects the majority of newborns to some degree, but distinguishing benign physiologic jaundice from pathological hyperbilirubinemia is critical for timely intervention. This calculator uses evidence-based nomograms to compare a baby's total serum (or transcutaneous) bilirubin level against age-specific thresholds, accounting for gestational age and clinical risk factors. Paediatricians, midwives, and parents can determine whether phototherapy or exchange transfusion may be warranted, avoiding unnecessary alarm while protecting against kernicterus—a serious neurological complication.

Last updated:

Creators Małgorzata Koperska, MD
5,320 people find this calculator helpful

Understanding Neonatal Jaundice

Jaundice in newborns results from elevated bilirubin, a yellow pigment produced during the normal breakdown of foetal haemoglobin. Most infants experience some degree of physiologic jaundice as their immature livers struggle to process bilirubin efficiently, exacerbated by rapid destruction of excess red blood cells after birth and diminished feeding in the first days of life.

The risk lies not in jaundice itself, but in severe hyperbilirubinemia. When bilirubin concentrations exceed age-specific thresholds, the pigment can cross the blood–brain barrier and cause kernicterus—irreversible damage to the basal ganglia and auditory system that manifests as cerebral palsy, hearing loss, or intellectual impairment. Modern phototherapy and exchange transfusion protocols have made kernicterus rare in well-resourced settings, but vigilance remains essential.

Clinical assessment requires measuring total serum bilirubin (TSB) or transcutaneous bilirubin (TCB), then plotting the result against nomograms that account for the baby's postnatal age, gestational maturity, and presence of risk factors such as isoimmune haemolytic disease, sepsis, or exclusive breastfeeding without supplementation.

Physiologic vs. Pathological Jaundice

Physiologic jaundice is the expected pattern in term and late-preterm infants. It emerges after 36 hours of life, peaks around day 3–5, and resolves within 1–2 weeks. Bilirubin levels remain below age-specific phototherapy thresholds, and stools and urine appear normal. This reflects the normal transition from foetal to neonatal haemoglobin metabolism.

Pathological jaundice demands urgent investigation and treatment. Warning signs include:

  • Onset within the first 24 hours of life
  • Bilirubin concentration exceeding the age-specific phototherapy threshold
  • Rapid rise (>0.2 mg/dL per hour)
  • Persistence beyond 2 weeks in term infants or 3 weeks in preterm infants
  • Acholic (pale) stools and dark urine, suggesting cholestasis or haemolysis

Pathological causes include isoimmune haemolytic disease (Rh or ABO incompatibility), bacterial or viral infection, polycythaemia, and metabolic disorders. Each requires specific investigation and management beyond phototherapy.

Bilirubin Thresholds and Risk Stratification

This calculator applies phototherapy nomograms published by the American Academy of Pediatrics and comparable international guidelines. The thresholds depend on three variables: the infant's age in hours, gestational age at birth, and the presence of neurotoxicity risk factors. Risk factors lower the phototherapy threshold, reflecting increased vulnerability to bilirubin toxicity.

Phototherapy threshold = PT(age − 1, risk factors, gestation)

Exchange transfusion threshold = TT(age − 1, risk factors, gestation)

  • age — Infant's postnatal age in hours. Must be adjusted to the exact time bilirubin was measured.
  • risk factors — Presence of any factor increasing neurotoxicity risk: isoimmune haemolytic disease, G6PD deficiency, asphyxia, significant lethargy, temperature instability, sepsis, or exclusive breastfeeding with poor intake.
  • gestation — Weeks of gestation at delivery. Preterm infants (<38 weeks) have higher thresholds than term infants because their livers mature more slowly.

Practical Considerations and Common Pitfalls

Accurate assessment requires careful attention to measurement timing, risk factor identification, and serial monitoring.

  1. Adjust age to the moment of measurement — If bilirubin was drawn 2 days after birth but checked today, use the age at the time of the blood draw, not the current postnatal age. A one-hour error can shift the threshold by 0.5–1 mg/dL, potentially triggering or deferring treatment unnecessarily.
  2. Do not confuse TSB with TCB without validation — Transcutaneous bilirubin (TCB) is convenient and non-invasive, but accuracy varies by skin pigmentation and device calibration. TSB remains the gold standard for treatment decisions. If TCB differs significantly from clinical suspicion, confirm with serum measurement.
  3. Reassess risk factors carefully — Exclusive breastfeeding without supplementation, sepsis, and haemolytic disease are often missed. A baby whose mother is Rh-negative but unsensitised may not be flagged as high-risk until haemolysis is confirmed. Document feeding volumes and stool output daily.
  4. Recheck bilirubin in non-haemolytic cases — Even physiologic jaundice can rise faster than expected. Recheck bilirubin within 6–24 hours of the first measurement in borderline cases, and plot each value on the nomogram to detect an accelerating trend that might warrant earlier treatment.

Phototherapy and Exchange Transfusion

When bilirubin concentration reaches the phototherapy threshold, treatment should commence promptly. Infants are exposed to blue-spectrum light (peak wavelength 460 nm) under special phototherapy units or on fibreoptic mattresses. The light isomerises bilirubin into water-soluble products that bypass hepatic conjugation and are excreted in urine and bile.

Phototherapy is typically continued for 24–36 hours, with interruptions for feeding and nappy changes. Eyes are protected to prevent retinal damage. Efficacy is highest when begun early, and frequent monitoring (every 4–6 hours initially) ensures levels are declining. Once bilirubin falls below the phototherapy threshold and the underlying cause is addressed, treatment is discontinued.

Exchange transfusion is reserved for severe hyperbilirubinemia approaching or exceeding the transfusion threshold, or when phototherapy has failed. In this procedure, the infant's blood is gradually replaced with donor blood (typically O-negative, CMV-negative), directly removing bilirubin and correcting any underlying anaemia. Exchange transfusion carries risks including infection, electrolyte disturbance, and thrombosis, so it is used only when the risk of kernicterus outweighs procedural risks.

Frequently Asked Questions

What is a normal bilirubin level in a newborn?

There is no single 'normal' value; thresholds depend on postnatal age, gestational maturity, and risk factors. A term infant at 72 hours with a TSB of 17 mg/dL may be at phototherapy threshold, while the same level at 48 hours would require treatment. Preterm and sick infants have lower thresholds because their brains are more vulnerable. Use age-specific nomograms to determine whether a level is safe or requires action. Your paediatrician will plot the result on the appropriate curve for your baby's circumstances.

Can I check bilirubin at home using a transcutaneous meter?

Transcutaneous bilirubinometry (TcB) is non-invasive and widely used for screening and monitoring, offering a convenient alternative to blood draws. However, accuracy is affected by skin pigmentation, oedema, and device calibration. Most guidelines recommend confirming results with serum bilirubin (TSB) before starting phototherapy, especially in darker-skinned infants where TcB tends to underestimate. Home devices exist, but results should be discussed with your paediatrician before making treatment decisions.

How quickly can bilirubin rise in a newborn?

In pathological jaundice or severe haemolytic disease, bilirubin can rise more than 0.2 mg/dL (3.4 µmol/L) per hour, doubling in 24 hours or less. This rapid rise is a red flag requiring urgent investigation and often phototherapy. In physiologic jaundice, the rise is gradual and predictable, peaking around day 3–5. Any baby with jaundice onset within 24 hours or unexpectedly fast bilirubin climb should be evaluated for haemolysis, infection, or metabolic disorder.

What feeding practices reduce the risk of hyperbilirubinemia?

Frequent breastfeeding (8–12 times per 24 hours) in the first days of life increases meconium passage and prevents milk stasis, both of which reduce bilirubin reabsorption. Colostrum is rich in laxative properties and caloric density. If breastfeeding is inadequate, supplementation with expressed breast milk or formula becomes necessary. Poor latch, maternal inexperience, and insufficient milk supply are common culprits; lactation support in the first 48 hours prevents many cases of pathological jaundice from breastfeeding failure.

Is phototherapy safe for newborns, and does it have side effects?

Phototherapy is safe and well-tolerated when administered correctly. The light is not UV and does not cause sunburn. Potential minor effects include loose stools, transient rash, and mild dehydration if fluid intake is not maintained. Eyes are protected with patches or shields, so retinal damage is prevented. The main risk is undertreatment—delaying phototherapy until bilirubin becomes dangerously high. As long as feeding continues and hydration is monitored, phototherapy is a highly effective, low-risk intervention that prevents kernicterus.

What are the long-term effects of neonatal jaundice?

Uncomplicated physiologic jaundice, even if moderately elevated, does not cause lasting harm. The brain is only vulnerable to bilirubin toxicity above specific thresholds, which phototherapy and exchange transfusion are designed to prevent. Kernicterus—the permanent neurological complication of severe untreated hyperbilirubinemia—is now rare. However, in low-resource settings without access to timely phototherapy or in cases of extreme delay in treatment, kernicterus can result in cerebral palsy, deafness, or developmental delay. Modern management with nomogram-guided treatment has virtually eliminated this risk in developed healthcare systems.

health
ACFT Calculator

More health calculators (see all)

Bladder Volume Calculator ACFT Calculator BMI for Women Calculator Birth Control Cost Calculator BMI for Teens Calculator BBT Calculator Padua Score Calculator HOMA-IR Calculator